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“Innovation is a process by which an idea or invention is 
translated into a good or service for which people will pay. To be 
called an innovation, an idea must be replicable at an economical 
cost and must satisfy a specific need” 
(BusinessDictionary.com)
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ABSTRACT
The poultry industry in Malaysia has played its role in contributing 
to the realization of agriculture as the third engine of growth and a 
high income economy, which is the goal of the new economic model 
(NEM) and food security. The industry has grown significantly at 
about 5.95% annually from 714,300 to 1.202 million metric tonnes 
from year 2000 to 2009, with total ex-farm value of RM5.468 billion 
or 53% of ex-farm value of the livestock industry. The total export 
of chicken products increased from RM54.44 million in 2007 to 
RM 350.68 million in 2009. In addition, 510 million metric tonnes 
of eggs was produced in 2009, with total ex-farm value of RM2.226 
billion or 22% of ex-farm value of the livestock industry. The 
industry has contributed 86% of livestock production and 75% of 
the ex-farm value of the livestock industry in the country. Poultry 
products are a major source of protein which is relatively cheap, 
easily available and acceptable to most or a majority of the society 
in the country and worldwide: we feed the world. The industry is 
run commercially by large-scale integrators and multi-national 
corporations and is an example of a success story in the livestock 
industry in the country, and could perhaps act as model for the 
livestock industry.  However, the industry is not free from many 
issues and challenges such as high production costs and emerging 
and reemerging diseases. To date, almost all known major poultry 
diseases have been reported in Malaysia. Thus, without proper 
management programmes and appropriate intervention the health 
and production of chickens, as well as the quality and safety of the 
products, can be badly affected. The success of chicken production 
depends to a significant degree on the flock health and prevention 
of diseases. Most problems related to disease in the chicken 
industry today are caused by the interaction of many factors where 
immunosuppression plays a key role and is a frequent problem in 
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chicken production. Control and prevention of poultry diseases 
involves complex understanding of the interaction of the agent, 
host and environment, and this can usually be achieved by proper 
biosecurity, vaccination and flock health programmes. It is difficult 
and expensive to maintain a high level of biosecurity at all times. 
Thus, poultry vaccines are powerful tools in disease control and 
prevention. Malaysia imports vaccines and pharmaceuticals worth 
RM 650 million annually and thus the Department of Veterinary 
Service is looking into ways of producing at least 30% of these 
vaccines locally. While there are 35 veterinary vaccine importers 
in Malaysia,  Malaysian Vaccines and Pharmaceuticals Sdn Bhd 
(MVP) is currently the sole veterinary vaccines manufacturer in the 
country. MVP manufactures 10 poultry vaccines against 4 important 
poultry diseases, namely the NDV4, FP, IBD UPM93, IBD, NDF, 
NDS, NDB1, NDLasota, NDB1/H120 and NDLa/H120. Of these, 
3 of the vaccines against 3 important poultry diseases, namely the 
NDV4, FP and IBD UPM93, are innovations from our research team 
at the Faculty of Veterinary Medicine, Universiti Putra Malaysia. 
The vaccines manufactured by MVP are for the local and export 
markets in ASEAN, Asia and West African countries. Recently, 
MVP Life Sciences Sdn Bhd, the second vaccine company in 
Malaysia, was established to focus on the manufacturing of tissue 
culture based-vaccines and a new generation of vaccines using 
bioreactors and latest technology in vaccine production. Innovation 
to produce safe and effective poultry vaccines, which are also cheap, 
efficient and better, is the priority in local vaccine production. 
This can be achieved through advanced knowledge in animal 
biotechnology and molecular biology. It appears that conventional 
type vaccines will still be the main type of vaccine produced in the 
near future, but new generation vaccines hold the promise of more 
advantages although there is a big horizon to explore before this 
becomes a reality.
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INTRODUCTION
The livestock industry in Malaysia has grown significantly from 
the year 2000 to 2009, at about 5.4% annually, with poultry and 
swine production dominating the local livestock scene with over 
100% self sufficiency and contributing 94.73% of the total meat 
and eggs produced in the country (Idris and Rahim, 2010) (Figure, 
1). It is indeed in line with the Third National Agricultural Policy 
(NAP3) launched in 1998, to increase the competitiveness of the 
agricultural sector in global trade and food security to ensure that 
there is sufficient and reasonably priced supply of basic food, and 
that each and every member of the family has access to enough 
food at any time to enable them to be active and healthy. 
 The poultry industry in Malaysia has evolved rapidly over 
the past 60 years almost on a similar pattern as that in advanced 
countries. The introduction of superior breeds, vaccines for disease 
control, high quality feed, advanced technology and favourable 
government policy have contributed to the transformation of 
subsistence poultry farming into a commercialized and advanced 
industry, with high productivity (Aini, 2005). The industry is 
run commercially by large-scale integrators and multi-national 
corporations. Peninsular Malaysia has been self sufficient in chicken 
meat production since 1960 and became a net exporter in 1983. The 
industry has grown at 5.95% annually with production increasing 
from 714,300 to 1.202 million metric tonnes from year 2000 to 
2009, with total ex-farm value of RM5.468 billion or 53% of ex-
farm value of the livestock industry. The total export of chicken 
products increased from RM54.44 million in 2007 to RM350.68 
million in 2009. In addition, 510 million metric tonnes of eggs was 
produced in 2009 with total ex-farm value of RM2.226 billion or 
22% of ex-farm value of the livestock industry (Idris and Rahim, 
2010) (Figures, 1, 2). It demonstrated that the industry has played 
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its part in contributing to the realization of agriculture as the third 
engine of growth and creation of a high income economy which is 
the goal of the new economic model (NEM) and food security. 
Figure 1  Production of livestock subsector in 2009 (X 103 MT). 
Source: Idris and Rahim (2010)
Figure 2  Ex-farm value of livestock subsector in 2009 (RM million). 
Source: Idris and Rahim (2010)
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 Chicken products have been a major source of protein which is 
relatively cheap, easily available and acceptable by most or majority 
of the society. The industry has not only provided enough healthy 
food to Malaysians, but also globally to people all over the world - 
we feed the world. The poultry industry is an example of a success 
story in the livestock industry in the country and could perhaps 
act as a model for the livestock industry in the country.  However, 
the industry is not free from many issues and challenges such as 
high production costs and emerging and reemerging diseases. To 
date, the number of poultry farms, flock sizes and density have 
all increased remarkably due to increasing domestic consumption 
and export opportunities. The management and housing systems 
have also changed towards more intensive systems and large units 
(Figures, 3a, b, c, d). This development could invite high risk of 
disease outbreaks and limited production. The recent increases 
in the costs of production and outbreaks of highly pathogenic 
avian influenza (HPAI) further threaten the industry (Hair-Bejo 
et al., 2006b). The worldwide movement of poultry breeding 
stock, poultry products, biologics, pet birds, free-flying migratory 
birds and waterfowls, are the additional means of introduction 
of disease agents from one country to another (Aini, 2005). As 
the commercial poultry industry continues to grow and change 
dramatically, to date almost all known major poultry diseases 
such as Newcastle disease (ND), infectious bursal disease (IBD), 
chicken anaemia virus (CAV), infectious bronchitis (IB), Marek’s 
disease (MD), lymphoid leukosis (LL), fowl pox (FP), adenovirus 
infections (FAdV), reovirus infections, avian encephalomyelitis 
(AE), infectious laryngotracheitis (ILT), HPAI, salmonellosis, 
fowl cholera, mycoplasmosis, complicated chronic respiratory 
disease (CCRD) and coccidiosis, have been reported in Malaysia 
(Hair-Bejo, 1992, 2005a, b; 2006a, c; Chowdhury et al., 2002a, 
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b, 2003; Hasmah et al., 2003, 2004; Zamri-Saad and Hair-Bejo, 
2006; Hair-Bejo et al., 2004b, 2005c; Hailemariam, et al., 2008; 
Ahmad et al., 2008; Jason et al., 2008; Abubakar et al., 2009; Tan 
et al., 2009a, b; Hair-Bejo and Bashir, 2010). Thus, without proper 
management programmes and appropriate intervention the health 
and production of chickens, as well as the quality and safety of the 
products, can be badly affected. 
(a)                                               (b)
(c)                                               (d)
Figure 3  Poultry housing and management system. (a) Free rearing, 
(b) Open house and (c and d) Close house systems.
 The economic impact of disease on the poultry industry comes 
not only from direct losses through death and interference with 
productivity but also from the cost of medication, vaccines, 
manpower and, in the case of some diseases, a ban on the export 
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of the meats, eggs and other chicken products. Successful chicken 
production depends to a significant degree on the health and 
prevention of diseases among the flock. Most disease problems 
in the chicken industry today are caused by interaction of many 
factors where immunosuppression plays a key role and is a frequent 
problem in chicken production (Jackwood, 1991). 
 Control and prevention of poultry diseases involves complex 
understanding of interaction of the agent, host and environment, and 
this usually can be achieved by proper biosecurity, vaccination and 
flock health programmes. Biosecurity encompasses management 
practices needed to prevent the spread of pathogens between farms 
and between buildings within a farm, and it is difficult and expensive 
to maintain a high level of biosecurity at all times. Thus, mechanisms 
involved in the defense against infections, especially viral infection 
has been shown to involve pathways of immunological reactions 
or vaccination. Ideally vaccines should induce lifelong protection 
against a pathogen without producing any signs of disease, reduce 
morbidity and subclinical infections, be safe, apathogenic, stable 
and easily delivered to a large number of chickens (Aini, 2005). 
 Three types of vaccines are available to the commercial poultry 
industry in Malaysia, namely the live attenuated and killed vaccines 
and the new generation of vaccines. Currently, Malaysia imports 
vaccines and pharmaceuticals worth RM 650 million annually and 
thus the Department of Veterinary Service is looking into ways of 
producing at least 30% of the total imported vaccines locally. There 
are 35 veterinary vaccine importers in Malaysia while Malaysian 
Vaccines and Pharmaceuticals Sdn Bhd (MVP) is currently the sole 
veterinary vaccines manufacturer in Malaysia. MVP manufactures 
10 poultry vaccines against 4 important poultry diseases, namely, 
the NDV4, FP, IBD UPM93, IBD, NDF, NDS, NDB1, NDLasota, 
NDB1/H120 and NDLa/H120. Of these, 3 of the vaccines against 3 
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important poultry diseases, namely the NDV4, FP and IBD UPM93, 
are innovations from our research team at the Faculty of Veterinary 
Medicine, Universiti Putra Malaysia (Hair-Bejo, 2006b; Hair-Bejo 
et al., 2006a) (Figures, 4a, b, c). The vaccines manufactured by MVP 
are used in local and export markets in ASEAN, Asia and West 
African countries, such as Indonesia, Thailand, Philippines, Hong 
Kong, Vietnam, Cambodia, Myanmar, Japan, Pakistan, Bangladesh, 
India, Egypt, Syria, Saudi Arabia, Kuwait, U.A.E, Timor Leste, 
Angola, Mozambique, Senegal, Ghana, Zambia, Sudan, Nigeria, 
Togo and Tanzania. 
 (a)                                     (b)                                  (c)
Figure 4   Three poultry vaccines which are innovation of UPM: 
(a) NDV4, (b) FP and (c) IBD UPM93.
 We are also actively involved in research and development of new 
generation of vaccines against IBD, ND, CAV, IB and HPAI (Phong 
et al, 2007; Nurulfiza et al., 2006b; Lim et al., 2008; Jalilian et al., 
2010). Research and development of new vaccines is vital to keep 
pace with the changes in the characteristics and pathogenicity of 
prevalent field viruses. Recently, a new spin-off or second vaccine 
company in Malaysia, namely, MVP Life Sciences Sdn Bhd, was 
established to focus on the manufacture of tissue culture based-
vaccines and a new generation of vaccines using bioreactors and 
latest technology in vaccine production. 
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 Knowledge of the pathogenesis of a disease is vital in 
understanding the pathogenicity and virulence of the agent, 
diagnosis of disease and development of safe and effective vaccines, 
in control and prevention of the disease. Our current and future 
innovations in poultry vaccines could ensure a safe and secure 
poultry industry in Malaysia and worldwide: Malaysian products 
for worldwide poultry disease control and prevention.
DISEASE
Disease is an adverse interaction between the agent, host and 
environment leading to structural or cellular damage (lesions) and 
functional abnormalities (clinical signs) (Figure, 5). The agent’s 
ability to infect a specific host is genetically determined and many 
viruses infect only one particular species. For instance, infectious 
IBD virus (IBDV), IB virus (IBV) and ILT virus (ILTV) exclusively 
affect poultry. Others are less specific, such as the ND virus (NDV) 
which seems capable of infecting humans with mild lesions, whilst 
the HPAI virus (HPAIV) and influenza A virus (H1N1) can cause 
death in humans (Calnek et al., 1991; Carlton and McGavin, 1995; 
Hair Bejo, 1995; Tan et al., 2009b; Abubakar et al., 2009). 
Figure 5  Concept and principle of disease.
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 Pathogenicity and virulence of viruses are determined by 
the virus genome. The virulence often depends on numerous 
factors such as adherence and antiphagocytic activity, and it is not 
surprising that it often depends on more than one gene. Changes 
in pathogenicity or virulence can take place easily, often involving 
only trivial changes in the genome. The presence of virulent markers 
in VP2 genes of IBDV, both in the restriction enzyme sites (BspM 
I, Sty I, Taq I, Ssp I Sac I and BstN I) and amino acid markers (Ala 
[222], Ile [242], Gln [253], Ile [256], Ala [284], Ile [294] and Ser 
[299], and serine-reach hepapeptide (“SWSASGS”), differentiate 
very virulent (vv) IBDV from the classical and variant strains. These 
changes result in serious outbreaks of the disease, first reported in 
late 1980s despite vaccination using classical IBDV strains. Up till 
today IBD outbreaks due to vvIBDV is still commonly reported in 
both vaccinated and non vaccinated chicken worldwide (Hair-Bejo, 
1992, 1993a, b,, 1994, 1996c; Carlton and McGavin, 1995; Chong 
et al., 2001; Hoque et al., 2001a, b, 2002; Kong et al., 2004a, b ; 
Phong et al., 2002a, 2003; Sharma et al., 2005; Tan et al., 2004a,b, 
c; Bahmaninejad et al., 2008; Nurulfiza et al., 2006a).
 The pathogenicity of a virus is often dramatically altered following 
repeated growth of the virus under unfamiliar circumstances outside 
the body. The laboratory passage of pathogenic IBDV in cultured 
cells leads to great reduction in pathogenicity in chickens and this 
has been a standard procedure for the production of live attenuated 
virus vaccine (Khor et al., 2004, 2005). Great reduction in the 
incidence of virus diseases in chicken is achieved through proper 
vaccination programmes in the farm. However, environmental 
factors such as biosecurity and stress factors also play a major role 
in the mechanism of virus infections (Liew et al., 2003; Mims, 
1990). Knowledge of the relationship of the lesions occurring in the 
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organs along with the cause and clinical signs, is vital in diagnosis 
of diseases (Hair-Bejo, 2005a). 
DIAGNOSIS OF DISEASE
Diagnosis of poultry diseases can be achieved based on the history, 
clinical signs, gross and microscopic lesions and detection and/or 
isolation and characterisation of the agent. In addition, therapeutic 
diagnosis can be used in cases such as in nutritional deficiency 
or toxicity (Hair-Bejo, 1995). Viruses, bacteria, parasites, fungus 
and mycoplasma are some of the common infectious agents in 
poultry diseases, whilst for non infectious agents, chicken are at 
high risk from toxic materials, traumatic injury and deficiency of 
certain essential trace elements. The dose, route, species, strains, 
virulence and source of the agent could determine the occurrence 
and severity of the disease. Environmental factors such as the 
temperature, humidity, ventilation, stress, nutrients, housing, light 
and climate also play an important role in disease development 
(Liew et al., 2003). The age, sex, species, breed, immunity, disease 
and nutritional status of the chickens are a few important host factors 
in the development of disease. 
 The gross and microscopic lesions of diseases can be 
pathognomonic, typical, important or non-specific lesions, whilst 
the affected chickens may die or be presented with typical or non-
specific clinical signs or sub-clinical signs such as increased (high) 
mortality or morbidity, poor feed conversion, retarded growth, 
reduced egg production, changes in egg quality, low fertility and 
poor hatchability (Hair-Bejo, 1994, 1995, 2002; Hair-Bejo et al., 
2005b). Diseases, whether clinical or sub-clinical are therefore 
an obvious deterrent to productivity. Thus, disease monitoring 
programmes, investigation and control are important to reduce the 
risk of losses, recommend measures for treatment and prevention, 
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and to control the factors causing disease and their interaction, 
respectively (Hair-Bejo et al., 2006b). 
PATHOGENESIS OF DISEASE
The effect on the interaction between the agent, host and 
environment at any step on the mechanisms of disease development 
is the major factor in determining disease production. Knowledge 
of the pathogenesis of a disease is vital in understanding the 
pathogenicity and virulence of the agent, diagnosis of disease and 
appropriate intervention in control and prevention of the disease 
(Figure, 6).
Figure 6  Concept and principle of pathogenesis of disease.
Route of  Entry and Defence Mechanism of  the Host 
Respiratory, gastrointestinal and intra-ocular routes are the most 
common pathways for agent infection in poultry. A mucociliary 
epithelium covers most of the surface of the lower respiratory tract. 
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It consists of single ciliated cuboidal and columnar cells together 
with single mucous secreting cells and subepithelial mucous 
secreting glands. Any foreign particles deposited on this surface 
epithelium can be entrapped in the mucous and borne upwards 
from the lungs to the back of the trachea by ciliary action. The 
nasal cavity of the upper respiratory tract has a similar mucociliary 
epithelium and any particles deposited there can also be carried to 
the back of the oral cavity and be swallowed or sneezed out from 
the cavity. Aggregations of lymphoid cells are also present in the 
lamina propria of the respiratory tract. These lymphoid cells play 
an important role in defence mechanisms against infectious agents. 
In contrast, it could also facilitate the entry of the agents, such as 
a virus, into the body. NDV, IBV, ILTV and HPAI are some viruses 
that commonly use the respiratory tract as the route of entry to cause 
infection in the host (Hodges, 1974; Cotran et al., 1989; Mims, 
1990; Hair-Bejo, 2005a).
 Contamination of feed and water, as well as various other 
swallowed materials originating from the mouth, nasopharynx 
and lungs, with infectious agents such as IBDV and CAV, would 
allow these pathogenic viruses to enter the body through the 
gastrointestinal route. The success of infection through the 
gastrointestinal tract is certainly affected by the presence of mucous, 
acid, enzymes and bile. Mucous protects epithelial cells, perhaps 
acting as a mechanical barrier to infection and contains secretory 
IgA antibodies that protect the immune chickens against infection. 
Viruses infecting by the intestinal route, such as IBDV, are often 
capable of surviving in the presence of acid, proteolytic enzymes 
and bile. IBDV is a nonenveloped single-shelled icosahedral capsid 
and is very resistant to physical and chemical agents (Hair-Bejo et 
al., 2004a, d).
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The morphology and epithelial lining of the intestinal tract is slightly 
different from the respiratory tract. The surface is made up of villi 
and crypt which is always in motion with constant changing of the 
epithelial cells or the enterocytes. Thus particles in the lumen are 
moved about a great deal. Infectious agents such as viruses are 
multiplied only in living cells and thus virus infection through the 
intestinal tract must make the most of what are primarily chance 
encounters with epithelial cells. The virus may form firm unions with 
receptor substances on the surface of intestinal epithelial cells, thus 
giving time for the penetration of the virus into the cells. Penetration 
of the virus into the cells may take place either by phagocytosis 
of the virus particle or by fusion of the virus surface with the cell 
membrane so that the contents of the virus particle enter the cells. 
Most epithelial cells, either respiratory or intestinal, are capable of 
pahgocytosis, but this is in small scale compared with specialist 
phagocytes, the macrophages and polymorphonuclear leucocytes. 
In chickens, lymphoid cell aggregations lay immediately below 
the intestinal epithelium at the lamina propria. The morphology of 
this lymphoid cell aggregation is almost similar to those of Payer’s 
patches in mammals. The epithelial lining within the lymphoid cell 
aggregation is highly specialized, the so called M cells. These M 
cells can take up particles and foreign proteins, delivering them to 
underlying immune cells with which they are intimately associated 
by means of cytoplasmic processes. A similar role could be played 
by the inter-epithelial leuckocytes (Hodges, 1974; Riddell, 1987; 
Mims, 1990; Hair-Bejo et al., 2004c).
 In the ocular region, the head-associated lymphoid tissues 
(HALT) or conjunctiva-associated lymphoid tissues (CALT) play an 
important role for initiation of virus infection. The HALT consists 
of two major lymphoid organs, namely the Harderian gland and 
CALT. The aggregations of these lymphoid tissues are important 
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for local immunity in the paraocular region of chickens as well as 
entry of agents into the body to cause infection. The ocular region 
and conjunctiva is kept moist and healthy by the continuous flow 
of secretion from the lachrymal and other organs. The secretions 
contain lysozyme, IgA and other antimicrobial substances and this 
may inhibit the opportunity for initiation of infection in the region. 
Infectious agents present in the ocular region may also be treated 
like inanimate particles of dirt or dust and be swept away via tear 
ducts into the nasal cavity (Hodges, 1974; Hair-Bejo et al., 2005b).
Primary Virus Entry and Replication 
Some of the most successful viruses such as ILTV and FP multiply 
in the epithelial surface of the respiratory tract and skin, respectively 
at the site of entry into the body, producing a spreading infection 
in the epithelium which is shed directly to the exterior. This is the 
simplest, most straightforward type of microbial parasitism. It takes 
at least a few days for antibodies or immune cells to be formed 
in appreciable amounts and delivered to the site of infection. The 
epithelial cells may be destroyed and inflammatory responses 
induced, but there is little or no virus invasion of underlying tissues. 
The infection is terminated partly by non immunogical resistance 
factors, and partly because most locally available cells have been 
infected. Interferons are important nonimmunological resistance 
factors. They are low molecular weight proteins, coded by the 
cell, and formed in response to infection with nearly all viruses. 
The interferon formed by the infected cell is released and can act 
on neighbouring or distant cells, protecting them from infection 
(Mims, 1990; Hair Bejo, 1995).
 However, for viruses that cause systemic infections and where 
the main target organ is away from the first site of entry or infection, 
the virus must first enter the blood or lymph. This means that after 
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gaining access through the epithelial lining of the respiratory or 
gastrointestinal tract or others, the virus needs to enter into the 
lumen of subepithelial lymphatic or blood vessel, either as a free 
virus or, alternatively, bounded within mobile cells or leucocytes 
that will carry it to other parts of the body or the target organ. The 
virus cannot replicate until it reaches a susceptible or target cells 
and in the absence or shortage of such cells infection would fail or 
be seriously hindered in spreading through the body and thus there 
will be failure of disease development (Hair-Bejo et al., 2004c, 
2005b).
 In virus infection, after entering the epithelial cell layer, the 
virus encounters the basement membrane. This membrane acts 
as a filter and to some extent can hold up the infection. However, 
following infection, functional integrity of the membrane is 
always damaged by inflammation or epithelial cell necrosis. Thus 
the invading virus is exposed to the host defence system, tissue 
fluids, lymphoid aggregation and phagocytic cells, as it reaches 
the subepithelial tissues. The interaction between the virus and the 
host defence system, especially the phagocytic cell, is a central 
feature of infection and pathogenicity. Phagocytes are designed 
to ingest, kill and digest invaders and the course of the infection 
depends on the success with which this is carried out. Virulent 
viruses have developed a great variety of devices for countering or 
avoiding the antimicrobial action of phagocytes. Viruses produce 
inflammatory products in tissues in the form of necrotic host cell 
materials or antigen-antibody complexes. Mononuclear infiltrates 
are also favoured in virus infections because the infected tissues 
themselves are often one of the sites for the immune response, 
with mononuclear infiltration and cell division (Cotran et al., 1989; 
Mims, 1990; Carlton and McGavin, 1995).
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Primary and Secondary Viraemia 
The blood is the most effective vehicle of all for the spread of 
infectious agents such as viruses throughout the body. After entering 
the blood the virus can be transported within a minute or two to 
a vascular bed in any part of the body. In systemic virus infection 
the epithelial surface at the first site of entry is traversed and the 
virus reaches the blood at an early stage, either via lymphatics and 
lymphoid cells or after entering the subendothelial blood vessel. 
The virus is then spread through the body via the blood stream, 
usually without any signs or symptoms. The virus may be carried 
freely in the plasma, in the form of elements of blood or in both 
compartments. The amount of virus at any given time may be 
negligible. This is called primary viraemia and is a common silent 
event often only known to have taken place because of invasion 
at a distant target organ. The localization of the virus in the organ 
depends on the ability of the virus to adhere to or grow in vascular 
endothelial cells and on phagocytosis by reticuloendothelial cells. 
The virus must also be resistant to any antimicrobial factors present 
in the plasma (Carlton and McGavin, 1995; Cotran et al., 1989; 
Mims, 1990). 
 After growth in the target organs there is a reseeding of the 
virus into the blood once again to give a secondary viraemia and 
infection of a fresh set of tissue. The secondary viraemia is of larger 
magnitude and often easily detected in blood samples. Viruses in 
circulation are exposed to phagocytosis by reticuloendothelial 
macrophages as long as they are free in the plasma. Killing of 
the virus could mean termination of the infection, whereas virus 
persistence and growth in macrophage could lead to infection in 
the organ harbouring the macrophages, with reseeding of progeny 
microorganism into the blood. The circulating virus could also 
invade the tissue by adhersion into the endothelial blood vessels, 
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preferably capillaries or venules, where circulation is slowest 
and the vessel wall thinnest. The virus then can reach tissues by 
leaking through the vessel wall, being passively ferried across the 
wall or by growing through the vessel wall. Protection of tissues 
from invasion by circulating viruses depends to some extent on the 
anatomical nature of the blood-tissue barrier or junction. One of the 
most important barriers to the spread of the virus into an organ is 
a layer of insusceptible cells that cannot be infected either through 
the capillary endothelial itself or other cells in extravascular tissues. 
Even if vascular endothelium is infected, subsequent events may 
be determined by the topography of budding. Viruses released 
exclusively from the luminal surface of the cell would contribute 
to a viraemia, but unless the cell is destroyed, tissue invasion 
would depend on liberation of the virus from the tissue side of the 
endothelial cells (Hair-Bejo et al., 1997).
 Capillaries in the central nervous system, connective tissue, 
skeletal and cardiac muscles are lined by a continuous layer of 
endothelium whereas those in renal glomerulus have fenestrated 
gaps in the endothelium. Once viruses have localized in the vessel 
wall, passage across the endothelium might be expected to be 
easier when there are fenestrated gaps. In all cases however, there 
is well defined basement membrane which must also be negotiated 
if viruses are to reach extravascular tissues. Circulating viruses 
localize readily on the capillary endothelium in inflamed areas or 
during repair of injury and on not well developed capillaries during 
foetal development. However, for localization in normal capillaries 
they must circulate in the blood long enough and in high enough 
concentrations. Therefore the faster the clearance of viruses from 
the body, by reticuloendothelial cells, the less chance there is 
for localization in capillaries. Removal of circulating viruses by 
reticuloendothelial cells, or their inactivation by serum antibody 
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and complement, constitutes the most important barrier to invasion 
of those organs that have the capillary bed. In a capillary which 
is well developed or not inflamed, initial localization of the virus 
presumably depends on attachment to receptors on endothelial cells 
(Cotran et al., 1989; Mims, 1990; Carlton and McGavin, 1995).
Cell and Tissue Damage in the Target and Other Organs
The impact on the host due to viral infection depends very much 
on the tissue involved. The central nervous system is particularly 
vulnerable to slight damage. However the effect on tissue is much 
less in the case of organs such as the liver or kidney, which have 
considerable functional reserves. More than two thirds of the liver 
must be removed before there are signs of liver dysfunction. Cell 
damage has profound effects if it is the endothelial cells of small 
blood vessels which are involved. The resulting circulatory changes 
lead to anoxia or ischemic necrosis in the tissues supplied by the 
vessels. Cell and tissue damage is sometimes due to the direct 
local action of the virus. When the virus grows in cells it causes 
early shutdown of RNA, protein and DNA synthesis in the host 
cell. Within a few hours there is an inevitable cytopathic effect 
and the cell dies (eg. pox viruses and herpes virus). Viral proteins 
accumulating in the cells during replication possibly have a toxic 
effect and contribute to cell damage. Cell membranes are generally 
the site of the initial damage, and interference with membrane 
function causes a leakage of cell material through the cell surface 
to the exterior and when lysosomes are affected there is lysosome 
enzyme leakage into cytoplasm and the cell undergoes autolytic 
destruction (Carlton and McGavin, 1995; Cotran et al., 1989; 
Mims, 1990). 
 The lesions in cells infected with viruses are generally non 
specific. The most common and potentially reversible change 
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is hydropic degeneration due to changes, particularly in the 
mitochondria. In irreversible conditions apoptosis and necrosis 
may occur. The nuclear chromatin moves to the edge of the nucleus 
(margination of chromatin) and becomes condensed (pyknosis). The 
presence of intranuclear and/or intracytoplasmic inclusion bodies 
under histological examination of the infected tissues is a quiet 
characteristic of virus infection. The inclusion often represents 
either cell organelles or virus factory in which viral components 
are being synthesized and assembled. Herpes virus (ILTV) and 
adenovirus (inclusion body hepatitis (IBH)) infections in chickens 
form intranuclear inclusions and pox viruses form intracytoplasmic 
inclusions (Figures, 7a, b). In ILTV infection syncytia intranuclear 
inclusion bodies are formed. Under ultrastructural examination, 
intracytoplasmic virus inclusions are commonly seen during active 
infection and replication of many viruses such as in IBDV infection 
(Hair-Bejo, 1995, 2005b; Voon et al., 2004). 
  
Figure 7  Intranuclear inclusion bodies. (a) IBH and (b) ILT. HE, 
1000X.
 The combination of antibody with antigen is an important event, 
initiating inflammatory phenomena that are inevitably involved in 
the expression of the immune response. In the infected host, those 
inflammatory phenomena are most of the time of great antimicrobial 
value, but they are nevertheless immunopathological features of 
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the infection, and immune complex reactions sometimes do a 
great deal of damage in the infected individual. The sequela of 
the reaction depends to a large extent on the size and the relative 
proportions of antigen and antibody. If there is a large excess of 
antibody, each antigen molecule is covered with antibody and is 
removed rapidly by reticuloendothelial cells which have receptors 
for the antibody molecule. When equal amounts of antigen and 
antibody combine, lattice structures are formed and these form large 
aggregates whose size ensures that they are also rapidly removed 
by reticuloendothelial cells. If, however, such as in corona virus 
infection (IB), complexes are formed in antigen excess, the poorly 
coated antigen molecules are not removed by reticuloendothelial 
cells. The molecules continue to circulate in the blood and have 
the opportunity to localize in small blood vessels elsewhere in 
the body such as the glomuruli. In the glomeruli the complexes 
pass through the endothelial pores and are deposited beneath 
the basement membrane. The localization of immune complexes 
and complement in the glomeruli can be associated with a local 
inflammatory response. There is an infiltration of polymorphs, 
swelling of the glomerular basement membrane, which may lead to 
membranous glomerulonephritis and glomerulosclorosis as well as 
severe necrosis of the renal tubules and deposition of urates in the 
affected area resulting to severe nephritis (Mims, 1990; Hair-Bejo, 
1995). 
 Certain viruses such as the herpes virus (Marek’s disease) 
and retroviruses (Lymphoid leukosis, Avian leukosis sub-group J 
(ALV-J)) undoubtedly cause tumors and this is to be regarded as a 
late pathological consequence of infection. The tumor virus genome 
can be integrated into the host cell genome, whether a tumor is 
produced or not, so that the virus becomes a part of the genetic 
constitution of the host. Sometimes the host cell is transformed 
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by the virus and converted into a tumor cell, the virus either 
introduces a transforming gene into the cell or activates expression 
of a pre-existing cellular gene. The transforming genes of DNA 
viruses generally code for T antigens which are necessary for 
transformation, and the transforming gene of RNA tumor viruses 
are known as onc genes (oncogenes) (Mims, 1990; Hair Bejo, 1995; 
Hair-Bejo et al., 2004b; Thapa et al., 2004a, b).
Death or Recovery from Virus Infection 
If there is to be recovery from infection, it is first necessary that 
the multiplication of the infectious agent be brought under control. 
The viruses must decrease in numbers and cease to spread through 
the body or cause progressive damage. This is accompanied by 
other factors, especially immunological factors. Otherwise the 
chicken will die due to failure of the vital organ/s resulting from 
the development of severe lesions in the organs due to the infection. 
In the process of recovery from an infectious disease, damaged 
tissue must be repaired and reconstituted. Sometimes the virus is 
completely destroyed and tissue sterilized, but often this fails to take 
place and the virus persists in the body, in some instances continuing 
to cause minor pathological changes and may cause persistent 
infections (Hair-Bejo, 1994, 1995; Hair-Bejo et al., 2004c) 
 The antibody plays a major part in the process of recovery in 
virus infections, especially for those viruses producing systemic 
diseases. The circulating specific antibodies will coat the surface 
of the free virus particles attachment to receptors of the target 
cells and thus it prevents infection from taking place. Antibodies 
that combine with the virus surface often block attachment and 
thus prevent infection of cells. Some attachment is not blocked, 
but the antibody nevertheless interferes with virus entry into the 
cell or with subsequent replication of the virus. The antibody also 
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promotes the uptake and digestion of virus by phagocyte cells, so 
that the virus-antibody complex is finally taken up and disposed 
off. Antibodies neutralizing virus infectivity are called neutralizing 
antibodies. Antibodies also act against viruses by clumping them, 
by destroying them with complement or by inducing inflammatory 
responses following their interaction with viral antigen (Cotran et 
al., 1989; Mims, 1990; Carlton and McGavin, 1995).
 The cell mediated immunity (CMI) also plays an important role 
in the process of certain virus infections, such as in the herpes and 
pox virus infections. Antibodies can neutralize free virus particles 
liberated from cells, but often fail to influence events in infected 
cells. Action on the infected cell seems necessary for recovery 
in some virus infections. The destruction of cells infected with 
viruses take place in various ways, but mainly depends on the 
mechanism of virus maturation in the cell. Many viruses such as 
IBDV replicate and produce fully infectious particles inside the 
cytoplasm. These particles are nucleocapsids, consisting of the 
basic nucleic acid core with its protein coat (capsid), and they are 
liberated from the cell and exposed to antibodies when it dies and 
disintegrates. Other viruses such as herpes viruses and paramyxo 
viruses do not have to wait for cell disruption, but are liberated by 
a process of budding through the cell membrane. The basic viral 
nucleocapsid in the cytoplasm becomes closely associated with 
the cell membrane, causing viral antigen to be incorporated into it. 
The virus particle finally matures by budding through the altered 
cell membrane, acquiring an envelope as it does so (Hair-Bejo, 
1993; Mims, 1990). In herpes type virus infections, virus antigen 
appear on the surface of the infected cells 12 - 24 hours before virus 
multiplication is completed, so that the cells can be destroyed early 
by CMI. Herpes viruses tend to spread directly from the cell without 
entering extracellular fluids, and antibodies cannot enter cells to 
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neutralize the virus. By acting directly on infected cells, immune 
cytolysis helps prevent this type of spread. Immune cytolysis has 
a similar action on cells infected with pox viruses. It appears that 
at the site of virus multiplication, T lymphocytes, in the course of 
their normal movement through the body, encounter virus antigens 
that have become bound to the surface of a macrophage or other 
antigen-presenting cell. When a T cell encounters the antigen to 
which it is specifically sensitized, the CMI response is initiated. The 
T cell differentiates and divides to give fresh supplies of specifically 
T cells. Lymphokines are liberated to attract macrophages and other 
leukocytes and focus them onto the site of infection. The infected 
cells are destroyed by cytotoxic T lymphocytes and other cells, and 
the virus material and cell debris is phagocytosed and disposed by 
activated macrophages. Once the multiplication of the infecting 
virus has been controlled, and the virus itself perhaps eliminated 
from the body, the next step in the process of recovery is to tidy 
up the debris and repair the damaged tissues (Cotran et al., 1989; 
Mims, 1990; Carlton and McGavin, 1995).
INFECTIOUS BURSAL DISEASE
Infectious bursal disease (IBD) or Gumboro disease is an important 
highly contagious immunosuppressive viral disease of chickens 
which poses a significant economical threat to the industry due to 
high mortality and immunosuppression (Hair-Bejo et al., 2004c). 
The disease was first recognised as a clinical entity in 1957 in 
USA (Cosgrove, 1962). Since then, IBD outbreaks have been 
reported worldwide, but have been relatively under control due to 
proper immunization programmes in poultry farms. However, in 
the 1980s very virulent (vv) and variant (va) strains of IBD virus 
(IBDV) emerged, which have caused serious disease problems in 
many countries over the past decade (Van Den Berg, 2000; Hair-
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Bejo, 1993a; Chettle et al.,  1989; Stuart, 1989). Many reported that 
vvIBDV are antigenically similar to the classical strains (caIBDV) 
(Synder 1990), but it is able to establish infection at high levels 
of maternal antibody which is usually protective against caIBDV 
strains (Chettle et al., 1989). Chickens which received IBD vaccine 
of caIBDV origin could not be protected against vaIBDV infections. 
The characterization of IBDV field isolates during disease outbreaks 
is vital for the right use of IBD vaccine and effective control and 
prevention of the disease. The caIBDV and vvIBDV strains cause 
moderate (25%) and high (75%) mortality, respectively, as well as 
immunosuppression in susceptible chickens, whilst the vaIBDV 
strains mainly cause immunosuppresion with relatively low 
mortality (5%) (Hair-Bejo, 1994).
 IBDV is a double stranded ribonucleic acid (dsRNA) virus in 
the genus of Avibirnavirus within the family Birnaviridae (Pringle, 
1999; Dobos et al., 1979). The target organ of the virus is the 
bursa of Fabricius, an important organ in the young chickens’ 
developing immune system. IBDV replicate and destroy the 
immature B-lymphocytes of the bursa of Fabricius resulting in 
severe and prolonged immunosuppresion. IBDV is a small, single 
capsid shelled non-enveloped virion with icosahedral symmetry, 
approximately 60nm in diameter (Hirai and Shimakura, 1974). The 
virus is very stable and relatively resistant physical and chemical 
agents (Mc Ilroy et al., 1989). The genome of the virus is designated 
as A and B (Hudson, 1986; Azad et al., 1985).  Segment A (~3.4 
kb) contains two open reading frames (ORFs) of 3,039bp and 
438bp, which partially overlap at the 5’ end of the genome (Azad 
et al., 1985). The large ORF encodes a precursor polyprotein (NH
2
-
VPX-VP4-VP3-COOH), which is autoproteolytically processed by 
cis-acting viral protease VP4 into VPX, VP3, and VP4 (Mundt et 
al., 1995). The VPX, VP2 and VP3 form the virus capsid. Highly 
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conformational epitopes were present in the VP2 protein that are 
responsible for induction of host neutralizing antibodies to confer 
protective immunity (Fahey et al., 1989). The VP2 gene is therefore 
an important target for cloning and expression which have high 
potential to be used for the development of subunit vaccines. VP3 
is the minor structural protein recognized by the non-neutralizing 
antibodies (Becht et al., 1988). Smaller ORF in segment A encodes 
the VP5 protein (Bayliss et al., 1990). The VP5 may be important 
in the pathogenesis of IBD since experimentally induced VP5-
defective virus was unable to cause bursal lesions.  Segment B 
(~2.8 kb) has single ORF encodes for the viral RNA-dependent 
RNA polymerase (RdRp) (Muller et al., 1979).  
Pathogenesis and Pathogenicity of  IBDV
Pathogenesis of disease is the sequence of events of an infectious 
agent starting from the point of entry to the host, to the entire 
development of lesions and appearance of the clinical signs. 
Knowledge on the pathogenesis of disease is vital in understanding 
the pathogenicity and virulenct of the agent, and in the diagnosis, 
treatment, control and prevention of the disease, to ensure good 
performance and health of the chicken, and minimal losses of 
production due to disease outbreaks (Hair-Bejo, 2005a). The 
gastrointestinal tract and intra-ocular routes are the most common 
pathways for IBDV infection in chickens. Contamination of feed 
and water, as well as various other swallowed materials originating 
from the mouth, nasopharynx and lungs, with IBDV would allow 
this pathogenic virus to enter the body through the gastrointestinal 
route. The success of infection through the gastrointestinal tract 
is certainly affected by the presence of mucous, acid, enzymes 
and bile. However, IBDV is often capable of surviving in these 
conditions. The virus will later attach and primarily replicate in the 
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lymphoid cell aggregations of the gut associated lymphoid tissues 
(GALT) (Hair-Bejo et al., 1997, 2000b, c, 2004d) (Figures, 8a, b). In 
the ocular region, the head-associated lymphoid tissues (HALT) or 
conjunctiva-associated lymphoid tissues (CALT) play an important 
role for initiation of virus infection. The HALT consists of two major 
lymphoid organs namely the Harderian gland and CALT (Figures, 
8c, d). The aggregations of these lymphoid tissues are important 
for local immunity in the paraocular region of chickens as well as 
entry of viruses into the body to cause infection (Thu-Zar et al., 
2000; Hair-Bejo et al., 2005a). 
(a)                                                 (b)
 
(c)                                      (d)
      
Figure 8  Primary replication of IBDV at site of entry. GALT (a) 
Control. HE, 200X, (b) IBDV infected GALT: positive for IBDV. 
Immunoperoxidase staining (IPS), 200X. CALT (c) Control. HE, Bar = 
50um, and (d) IBDV infected CALT: positive for IBDV. IPS, Bar = 50um.
❚❘❘ 30
Poultry Vaccines:  An Innovation for Food Safety and Security
 Following primary replication of the virus in the lymphoid 
tissues, at the first site of entry or infection, the virus will enter the 
blood circulation to get access into the target organ. This is called 
primary viraemia and is a common silent event, often only known 
to have taken place because of invasion at a distant target organ, 
the bursa of Fabricius. After massive replication of the virus in the 
target organ, there is a reseeding of the virus into the blood to give 
a secondary viraemia and infection of a fresh set of tissue (Hair-
Bejo et al., 1997; Hair-Bejo et al., 2005a; Roosevien et al., 2005; 
Tasfaheywet et al., 2008) (Figures, 9a, b, c). 
Figure 9  Replication of IBDV in the lymphoid cells of the bursa 
Fabricius. (a) Intracytoplasmic inclusion body. TEM, Bar = 2um. (b) 
Virus particles emerged from the inclusion bodies. TEM, 60K. (c) 
IBDV particles. TEM, 80K.
 The impact on the chicken due to different strains of IBDV 
infection depends very much on the tissue involved. Severe damagd 
of the lymphoid organs/tissues during secondary viraemia and 
thereafter, due to vvIBDV infection, could lead to high mortality 
and severe immunosuppression in the surviving chickens (Figures, 
10a, b, c, d). In contrast, the lesions caused by caIBDV infection 
is rather less severe when compared to the vvIBDV infection and 
immunosuppresion recorded if the chicks were infected with the 
virus at below 2 to 3-weeks-old, while if the infection occurs at 
a later age, it could cause lowes percentage of mortality than the 
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vvIBDV infections. The vaIBDV only causes immunosuppresion 
and damagd of the lymphoid organs, especially the bursa of 
Fabricius. The infected chicken is highly susceptible to other 
pathogenic pathogens and died later due to secondary infection 
(Hair-Bejo, 1994).
(a)                                 (b)
(c)                               (d)
(e)                              (f)
Figure 10  Typical gross lesions of chicken infected with vvIBDV. 
(a and b) Haemorrhages of the bursa Fabricius, (c and d) Gelatinous 
materials covering the serosal surface of the bursa Fabricius, and 
necrosis and haemorrhages of the mucosa, (e) Haemorrhages of 
muscles, and (f) Haemorrhages of the mucosa at the junction between 
proventriculus and gizzard.
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 It is interesting to note that the interaction between the agent, 
host and environment at any steps during the mechanisms of disease 
development is the main factor to determine disease production. 
Any intervention at any of the steps could prevent the occurrence 
of disease and is the principle for disease control and prevention. 
Detection and Characterisation of  IBDV
Microscopic examination of the bursa of Fabricius with lesion 
scoring is useful and can be routinely used in diagnosis of IBD 
especially when other diagnostic aids are not available (Hair-Bejo, 
1993; Hair-Bejo et al. 2005b), although in principls other specific 
tests are required to confirm the diagnosis. It is fast, cheap and can 
be easily made available and can also be used in the monitoring of 
vaccination efficacy (Hair-Bejo, 2002; Hair-Bejo et al., 2005b). It is 
important to note that the severity of lesions in the bursa of Fabricius 
is an important indicator to determine the immunosuppressive 
effect of the virus. Bursa of Fabricius is a central lymphoid organ 
of chickens and the target organ for all strains of IBDV.  It was 
reported that a few live IBD vaccines could induce high levels of 
IBD antibody, but at the same time cause severe bursal lesions. 
Thus, the chickens will be protected against IBDV field challenged, 
but is also immunosuppressed and highly susceptible or dies due to 
secondary infection by other pathogens (Hair-Bejo, 1994). Thus, 
examination of bursal lesions is a must to ensure the efficacy of 
IBD vaccines. The usage of immunohistochemistry and electron 
microscopy techniques in the detection of the agent or antibody 
against IBDV could confirm diagnosis of IBD outbreaks (Hair-
Bejo et al., 2004c), although the technique is not always available. 
 Recently, various types of enzyme-linked immunosorbent 
assay (ELISA) techniques namely, indirect, double antibody 
sandwich (DAS) and reverse transciptase nested polymerase chain 
reaction (RT-Nested PCR) ELISAs, to be used in the diagnosis 
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and monitoring of IBD, were successfully developed (Phong et 
al., 2002b, 2003; Hair-Bejo et al., 2006d, e, f; Nurulfiza et al., 
2008). The development of polymerase chains reaction (PCR) 
methods, namely reverse transciptase PCR (RT-PCR) and restriction 
fragment length polymorphism (RFLP) assay, and the use of 
various bioinformatics software enabled us to detect and holistically 
characterise IBDV strains (Chong et al., 2001;  Hoque et al., 2001, 
2002; Phong et al., 2002b; Tan et al., 2004a;  Khong et al., 2004a, 
b; Sharma et al., 2004, 2005; Hair-Bejo et al., 2006g; Nurulfiza 
et al., 2006a;, b, c; Bahmaninejad et al., 2008), and determine the 
source of origin. A more rapid and sensitive SYBR Green I based 
real-time PCR was also developed for rapid detection, quantification 
and differentiation of IBDV subtypes (Omar, 2005; Hair-Bejo et 
al., 2006c, Hairul-Aini et al., 2008) (Figures, 10a, b, c, d).
(a)                                         (b)
(c)                                         (d)
Figure 11  Diagnostic kits for IBD invention of UPM. (a) Indirect 
ELISA, (b) DAS ELISA, (c) RT-Nested PCR and (d) SYBR Green I 
based real-time PCR.
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IBD Vaccines and Vaccination
Three types of vaccines are currently available to the commercial 
chicken industry: the live attenuated and killed vaccines, and the 
new generation of recombinant vaccines. The aims of vaccination 
are for the B cells to synthesise and secrete antibodies that could 
neutralise invading agents or serve as anchor molecules for cellular 
cytotoxicity. T cells are necessary for optimal B cell response. 
Though B cells are able to respond to free antigen, an optimal 
response will only be achieved if at the same time an efficient T 
helper response is induced. Therefore, every successful vaccination 
should also aim at T cell activation. The ultimate goal of vaccination 
is to induce an immune response that will protect chickens directly 
by the induction of antibody and cell mediated immunity, and result 
in the induction of immunological memory. A subsequent infection 
by virulent organisms either fails to cause disease in the face of 
active immunity or induces a rapid memory response that clears 
the infection without loss of performance. Vaccination should be 
carried out at a time when the host is immunologically competent. A 
rational vaccination programme also requires the vaccine antigens to 
be presented in the most immunogenic form (Omar, 2005). Ideally, 
vaccines should induce lifelong protection against a pathogen 
without producing any signs of disease, and reduce morbidity and 
subclinical infections. Vaccines must also be safe, apathogenic, 
stable and easily delivered to large numbers of chickens (Hair-Bejo 
et al., 2004b, e, 2006a; Hair-Bejo and Aini, 2008). 
 Vaccination is the major tool for the prevention and control of IBD 
in the poultry industry. Types of vaccine, time of vaccination, level 
of maternally derived antibody in the chicks and IBDV field strains 
are some important factors to be considered to ensure effective 
vaccination programmes (Hair-Bejo et al., 2004b, e; Chulan et al., 
1998; Zulkifli, et al., 1997). Some chickens immunized with live 
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attenuated IBD vaccines showed a certain degree of bursal atrophy 
and immunosuppression that interferd with other vaccinations 
(Hair-Bejo et al., 2006a; Tsukamoto et al., 1995; Muskett et al., 
1985). Live attenuated vaccines are usually developed from the 
field or wild virus attenuated in chicken embryonated eggs or tissue 
culture. The vaccine virus could replicate effectively in the target 
organ of the chickens and could induce protective immune response 
similar to natural infection. However, it may have the risk associated 
with the potential for reversion to a virulent phenotype (Muskett 
et al., 1985). Inactivated or killed vaccines are typically safe, but 
less effective than live attenuated vaccines (Van den Berg, 2000). 
The vaccine virus is not able to replicate in the chickens and the 
immune responses of the virus can be enhanced by adjuvants and 
immunomodulators such as the conventional oil based adjuvants, 
plant extracts, bacterial products, toxins, various cytokines and 
genes with immunomodulator effects such as TLR, HSP and CpG 
(Omar, 2005). 
 Alternatively, in recent years, the recombinant technology 
to express structural proteins of IBDV has been used as subunit 
vaccines. A subunit vaccine overcomes the risk of reversion. As the 
main host protective antigen harboring most of the neutralization 
sites, VP2 has been used for the development of subunit vaccines 
and has been expressed in a number of systems such as avian 
herpesvirus vector (Tsukamoto et al, 2002), fowlpox virus vector 
(Shaw and Davison, 2000), fowl adenovirus vector (Francois et al., 
2001), Marek’s disease virus vector (Tsukamoto et al., 1999) and 
Semliki Forest virus vector (Phenix et al., 2001). However, these 
methods are costly and complicated. Alternatively, expression of 
VP2 as the recombinant protein in systems including E. coli (Rong 
et al., 2005; Rogel et al., 2003), yeast (Pitcovski et al., 2003) and 
insect cells (Dybing and Jackwood, 1998) were explored. VP2 
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expressed in yeast and insect cells proved to be effective, but the 
cost is high. Alternatively there is production of virus-like particles 
of IBDV, where the virus-like particles resemble the native viral 
capsids structurally and immunologically and elicit excellent 
antibody responses (Kibenge et al., 1999), but the cost of production 
and risk of reversion are also high. In contrast, the E. coli expression 
system is still known to be the fastest, easiest and an inexpensive 
technique used to express usable amounts of recombinant protein, 
although it has been reported that the recombinant VP2 expressed 
in E. coli is often hampered by low expression levels and low 
solubility. In contrast, improved expression level and solubility 
has been reported in other studies and a recombinant VP2 gene 
of vvIBDV cloned into an E. coli expression system vaccinated 
in specific pathogen free (SPF) chickens could provide 75-100% 
protection against vvIBDV challenged (Nurulfiza et al., 2006b; 
Omar et al., 2006; Saadun et al., 2005). The development of reverse 
genetic and live mutant IBD vaccines as well as transgenic plants 
is of much interest and may be available to be used in the field in 
the near future. 
 In addition various routes of vaccination and types of vaccine 
preparation, such as the immune complex vaccine used for in ovo 
or hatchery vaccination, could improve the efficacy of IBD vaccines 
(Hair-Bejo et al, 2000b). IBD vaccines also have high potential to 
be given via feed especially for free rearing or backyard chickens 
to ensure that they are free or protected against IBDV challenges 
(Hair-Bejo et al, 2004a). These groups of chickens can be a source 
of IBDV infection on commercial chickens and may complicate 
control and preventive measures for IBD outbreaks. 
37 ❘❘❚ 
Mohd Hair Bejo
Control and Prevention of  IBD
Control and prevention of IBD in chicken can be achieved in 
principle with proper vaccination programmes and biosecurity. 
Biosecurity encompasses management practices needed to prevent 
the spread of pathogens between farms and between buildings 
within a farm. Effective biosecurity to prevent the spread of the virus 
can be achieved with proper usage of disinfectants or, alternatively, 
electrochemical (ECA) products. It may be difficult and expensive 
to maintain a high level of biosecurity at all times. Thus, so far 
mechanisms involved in the defence againss IBD infections have 
been shown to involve pathways of immunological reactions. Proper 
flock health programmes should be practiced regularly at fixed times 
on a flock of chickens based on the epidemiology of the disease. 
The production performance as well as the feed and water intakes, 
mortality and morbidity rates, diagnosis of disease outbreak, 
vaccination responses and disease prevention should be monitored. 
The effectiveness of the programme should also be evaluated. The 
data should be analysed and evaluated intelligently in order to 
take the necessary actions for disease control and prevention.  The 
control and prevention of diseases with characteristic clinical signs 
or symptoms, especially for those with high mortality, are relatively 
easy to achieve as these diseases are easy to recognise and diagnose, 
and cause direct impact on the health and production of the chickens. 
However, for the immunosuppressive diseases such as IBD, high 
mortality may not be observed during the initial stage of infection, 
but the performance of the affected chicken will be poor and they 
may die in the late stage of infection due to secondary infection by 
other pathogen/s (Hair-Bejo et al., 2006b).
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Development and Commercialisation of  MyVAC UPM93 IBD 
Vaccine
In 2005, we successfully developed and commercialised a safe and 
effective MyVAC UPM93 IBD vaccine for chickens, specifically 
against vvIBDV field challenged. The vaccine’s seed virus was 
novel and unique with molecular characteristics of the viral protein 
of the virus, having highly homology to vvIBDV field strains in 
Asia and Europe. This seed virus was isolated from the Poultry 
Farm, Universiti Putra Malaysia in 1993. The vaccine has passed 
all the laboratory tests required for dossier, such as tests for safety, 
sterility, back into virulent, virus titre and freedom from extraneous 
viruses. In 2004, field trials were conducted in commercial broiler 
chicken farms in Johor, Selangor and Perak, and it was proven 
that MyVAC UPM93 IBD is safe, effective and able to induce 
high and protective levels of IBD antibody even in chicken flocks 
with different levels of maternally derived antibody. The vaccine 
only caused mild to moderate bursal lesion with bursal recovery, 
without causing immunosuppression, interruption of body weight, 
FCR and performance of the chickens. Both the laboratory and field 
studies demonstrated that MyVAC UPM93 IBD vaccine is safe and 
effective in controlling and preventing vvIBDV field challenged 
in commercial chickens. The vaccine is currently available in 
the market and can be obtained from Malaysian Vaccines and 
Pharmaceutical Sdn Bhd. (Figures, 12 a, b).
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(a)                                        (b)
Figure 12   IBD vaccine innovation of UPM. (a) MyVAC UPM93, (b) 
Immunogold stained IBDV. TEM, Bar = 100nm.
 The research and development (R&D) of MyVAC UPM93 IBD 
vaccine, prior to discussion on commercialisation potential with 
the vaccine companies, took about 8 years. Subsequently, just 5 
years later, after agreement and completion of registration dossier 
and being approved by the authority, the vaccine was successfully 
launched for commercialisation in 2005. 
 Briefly, the first stage of R&D involved IBDV isolation, 
identification and characterisation using both the conventional and 
molecular techniques. The isolates were propagated in the SPF 
embryonated chicken eggs and tissue cultures. The pathogenicity 
and immunogenicity of the isolates were determined in SPF 
and commercial chickens in the experimental house. The highly 
pathogenic isolates were selected for the challenge virus, whilst 
isolates with low pathogenicity and good immunogenicity were 
selected as potential candidates for the development of the IBD 
vaccine. Further, pathogenicity and immunogenicity tests were 
conducted for the isolates, prior to the final selection of the best 
isolate, one for vaccine development and the other for IBDV 
challenge virus.  
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 A local isolate of IBDV, identified as UPM93, was selected from 
more than 20 vvIBDV of local isolate, adapted and successfully 
attenuated in SPF embryonated chicken eggs and tissue cultures 
for the development and production of the Malaysian IBD vaccine, 
MyVAC UPM93. The isolate showed low pathogenicity with good 
immunogenicity when inoculated in both the SPF and commercial 
chickens. The seed IBDV was prepared and tested to be free from 
any extraneous agents, other viruses, bacteria and mycoplasma, 
using both the conventional and molecular techniques.
 The second stage of R&D involved study on the pathogenicity 
and immunogenicity of the IBD seed virus, in both SPF and 
commercial chickens under experimental conditions. The efficacy, 
safety, immunosuppressive effect, routes of vaccination and 
vaccination in SPF and commercial chickens were determined. 
A safe and effective IBD viral seed was successfully developed 
to confer protection against vvIBDV of field isolate, in both the 
SPF and commercial chickens under experimental conditions. The 
seed virus is effective to be used either via the intraocular, oral or 
in ovo route of vaccination. UPM 93 is highly immunogenic and 
able to neutralize high levels of IBD maternally derived antibody. 
It is able to confer full protection against vvIBDV field challenged, 
and is non immunosuppressive with mild bursal lesions and bursal 
recovery (Hair-Bejo, 2006b; Hair-Bejo et al., 2006a).
 Market study was conducted prior to commercialisation and sale 
forecast  determined (Ali et al., 1988). Discussion with potential 
companies for commercialisation was conducted in 2000, and in 
2001 the IBDV Master seed was handed over to the company for 
mass production of the IBD vaccine. The IBDV Mater seed virus 
was further tested for safety, efficacy, immunosuppressive and 
protective effects, minimum immunogenic dose and revision to 
virulence in SPF chickens. Briefly, the test demonstrated that the 
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Master seed is safe to be used in highly susceptible SPF White 
Leghorn chickens. It passed the purity and identity tests and freedom 
from extraneous agents, and proved for absence of revision to 
virulence following ten back passages of the working seed virus 
in SPF chickens. The vaccine is effective to confer full protection 
against vvIBDV challenged, safe and show bursal recovery. It does 
not interfere with ND vaccination. The shelf life of the vaccine is 
good and acceptable (Figures, 13a, b, c).  
(a)                                    (b)
(c)
Figure 13  MyVAC UPM93 IBD vaccine production in GMP Certified 
laboratory. (a) SPF embryonated chicken eggs inoculated with the 
virus, (b) Freeze drying of the vaccine, (c) Labeling of the vaccine. 
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A series of field trials were conducted in broiler farms in Johor, 
Selangor and Perak on the basis of their recent history of IBD or 
Gumboro outbreaks and as representatives of the Southern, Middle 
and Northern regions of the West Coast of Peninsular Malaysia, 
in 2004. The time of vaccination and management followed the 
common practice of the farms. The chickens in the control and 
vaccinated groups were challenged with vvIBDV. The study proved 
that MyVAC UPM93 IBD vaccine is effective in preventing further 
outbreaks of IBD in the flocks where the trials were held. It was a 
safe and efficacious vaccine under field conditions when used in 
flocks with either relatively low or high maternally derived antibody 
(MDA) to IBD and does not result in interference with the response 
to routine Newcastle disease vaccination. It induces antibody titre 
above the protective level (1000 ELISA unit) at 14 and 21 days 
post vaccination. The total percentages of mortality and FCR in the 
farms remained low throughout the trials (Figure, 14).  
Figure 14   IBD antibody titre (ELISA unit). MyVAC UPM93 induced 
high antibody titre and provided full protection against vvIBDV, field 
challenged.
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 The vaccine was packaged and labeled. An instruction pamphlet 
was prepared to describe the composition and characteristics of the 
vaccine, methods of vaccination and dosage, storage conditions and 
precautions. The dossier were prepared and submitted for approval 
to the authority at the Department of Veterinary Services, Malaysia. 
Signing of Memorandum of Agreement between Universiti Putra 
Malaysia and Malaysian Vaccine and Pharmaceutical Sdn Bhd 
and launching of the vaccine for commercialization was held in 
September 2005. The study was supported by the government of 
Malaysia under the IRPA grant,  during the 6, 7 and 8th Malaysia 
Plan, as part of the projects, and ITAF 2. In recognition of the 
innovation and achievements, MyVAC UPM93 IBD vaccine has 
been awarded “The Best Researcher Award on Commercialisation 
2005, by UPM and the “National Research Innovation Award 
between Public and Private Sector 2008” by MOSTI (Figure, 15).
Figure 15  The National Research Innovation Award between Public 
and Private Sector 2008 by MOSTI in recognition of MyVAC UPM93 
IBD vaccine innovation and achievements.
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NEW GENERATION OF POULTRY VACCINES
Recombinant Vaccines
The virus proteins are expressed in bacteria, yeast, insects or 
mammalian cells. It is an alternative application using recombinant 
DNA technology for production of hybrid virus vaccines. The 
recombinant virus vaccine can multiply in infected cells, producing 
antigen of a wide range of virus. It is classified as live vector vaccines 
and naked DNA vaccines with no or low adverse side effects, 
relatively cheap, simple to produce, ease of administration, stable, 
adjuvant free and could confer protection against more than one 
antigen (insertion of one or more genes expressing immunogenic). 
Hybrid vaccines are stable and stimulate both cellular and humoral 
immunity (Shaw and Davison, 2000; Rogel, et al., 2003; Pitcovski, 
et al., 2003; Nurulfiza, et al., 2006b; Phong, et al, 2007) . 
Subunit Vaccines 
Subunit vaccine consists of virus proteins that the immune system 
recognizes and makes antibodies for certain proteins on the virus 
and not the whole virus. Subunit vaccines may have great advantages 
over the conventional vaccines as it can be produced much faster 
and are safer than making vaccines using SPF embryonated chicken 
eggs. A subunit vaccine (synthetic peptide), consists of a single 
protein either purified from conventionally produced vaccine or 
produced by recombinant DNA technology. Peptide vaccines are a 
further reduction of subunit vaccines to minimal epitope required 
for induction of protection. Development depends on identification 
of the immunogenic site and hence is not applicable to all viruses, 
and do not readily stimulate T cells, thus requiring coupling to a 
protein carrier. However synthetic peptides vaccines are chemically 
well defined, selective and safe, with no cold chain requirements 
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and thus can be cost effective and practical in tropical countries. 
The multi-mimotope protein r5EPIS promises to be a novel subunit 
vaccine candidate for IBDV (Wang, et al., 2007).
 
DNA-based Vaccines
DNA-based vaccines consist of a segment of viral DNA and are 
different in structure from conventional vaccines. They consist of 
plasmids, small rings of double-stranded DNA originally derived 
from bacteria, totally unable to produce an infection. The plasmids 
used for immunization have been altered to carry genes specifying 
one or more antigenic proteins, normally made by a selected 
pathogen. When it is injected into the body, the artificial DNA is 
taken up by cells, which translate the DNA into viral proteins. This 
triggers the immune system to produce antibodies for the viral 
proteins, therefore providing protection against infection. DNA-
based vaccine is relatively cheap, fast to produce, stable to store and 
will never be able to cause infection. The vaccine could be given 
using an air gun, by shooting a tiny DNA-covered particle under 
the skin (Jalilian, et al., 2010; Lim, et al., 2008). 
Reverse Genetics
A mutant viral vaccine, which lacks a specific gene encoding a 
highly immunogenic protein, is useful in eradication programmes 
as it allows differentiation between the infected and vaccinated 
chickens (DIVA vaccines). Genetic vaccines are capable of eliciting 
humoral and cellular immunity, are safe, fast to develop, stable and 
easy to formulate into multivalent vaccines (Noue¨n, et al., 2006; 
Moura, et al., 2007).
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Transgenic Plant Vaccines
A novel method of vaccination based on convenience of oral 
immunization. It eliminates the need for trained staff for vaccine 
administration, cold chain storage, transportation, cost of syringes 
and very practical in free rearing of chickens. The expression level 
of VP2 protein of IBDV in transgenic rice seeds varied from 0.678 % 
to 4.521 % µg/mg of the total soluble seed protein (Wu et al., 2007).
CONCLUSIONS
The success of the poultry industry in the country and worldwide 
depends to a significant degree on the health and production of 
the chickens. The threat of infectious diseases, either emerging or 
reemerging diseases, will continue in the industry and thus poultry 
vaccines are powerful tools in disease control and prevention. R&D 
are important elements in the industry and innovation to produce a 
safe and effective vaccine, either the conventional or new generation 
of poultry vaccines which is also cheap, efficient and better, is the 
priority in any vaccine development and production. This can be 
achieved through advanced knowledge in animal biotechnology and 
molecular biology. However, only a small percentage of inventions 
from R&D end up in commercialisation especially in developing 
countries like Malaysia. The lack of local and international 
manufacturing companies based in the country could explain this 
failure. Furthermore, it will be only economical and cost effective 
if the company, as well as the product, is able to compete not only 
in the local market, but also internationally. 
 It appears that conventional vaccines will still be the major 
vaccine produced in the near future, but new generation vaccines 
hold promise of more advantages ahead although there is a big 
horizon to explore before this becomes a reality. Poultry vaccines 
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not only protect chickens from death or poor performance, but also 
reduce or prevent the use of antibiotics and other toxic chemicals 
and thus ensure the safety and quality of chicken products. The 
poultry industry is an excellent model for the livestock industry 
in the country with annual growth of about 5.95%, 100% self 
sufficiency and with about 15% of total production exported. This 
achievement must be sustained and further improved in line with 
NAP3 and NEM through proper disease control and vaccination 
programmes.
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